南非 - 英文 - South African Health Products Regulatory Authority (SAHPRA)

fresenius kabi manufacturing sa (pty) ltd - injection - see ingredients - each 1 ml ampoule contains pentazocine 30 mg

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - pentazocine hydrochloride 28.2mg equivalent to 25 mg pentazocine;   - tablet - 25 mg - active: pentazocine hydrochloride 28.2mg equivalent to 25 mg pentazocine   excipient: calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch microcrystalline cellulose sodium metabisulfite

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - pentazocine hydrochloride 56.4mg equivalent to 50 mg pentazocine;   - tablet - 50 mg - active: pentazocine hydrochloride 56.4mg equivalent to 50 mg pentazocine   excipient: calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch microcrystalline cellulose sodium metabisulfite

尼日利亚 - 英文 - NAFDAC (National Agency for Food and Drugs Administration and Control)

pentazocine 30mg

尼日利亚 - 英文 - NAFDAC (National Agency for Food and Drugs Administration and Control)

pentazocine bp 30mg/ml

尼日利亚 - 英文 - NAFDAC (National Agency for Food and Drugs Administration and Control)

pentazocine 30mg/ml

坦桑尼亚 - 英文 - Tanzania Medicinces & Medical Devices Authority

lincoln pharmaceuticals limited, india - pentazocine injection bp 30 mg/ml - solution for injection - 30

南非 - 英文 - South African Health Products Regulatory Authority (SAHPRA)

pfizer laboratories (pty) ltd - injection - see ingredients - each vial contains piperacillin sodium equivalentt to piperacillin 4 g tazobactam sodium equivalent to tazobactam 500 mg

马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - piperacillin; tazobactam -

以色列 - 英文 - Ministry of Health

neopharm ltd - piperacillin as sodium 2 g/vial; tazobactam sodium 0.25 g/vial - powder for solution for injection - piperacillin and enzyme inhibitor - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.